CytoSorbents REFRESH 2-AKI Protocol Amendment Approved by FDA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/31/2026

1. META
2. MSFT
3. AMZN
4. FTNT
5. QCOM
6. ARM
7. AAPL
8. SBUX
9. TENB
10. CVNA

Go back to CytoSorbents REFRESH 2-AKI Protocol Amendment Approved by FDA
Cytosorbents Corporation (NASDAQ: CTSO) Delayed: 0.35 --0 (-0%)
Previous Close $0.35    52 Week High $7.48 
Open $0.36    52 Week Low $3.11 
Day High $0.36    P/E N/A 
Day Low $0.35    EPS $-0.03 
Volume 43,961